Related Experiment Video
Updated: Nov 3, 2025

A Non-random Mouse Model for Pharmacological Reactivation of Mecp2 on the Inactive X Chromosome
Published on: May 22, 2019
Tau Exon 10 Inclusion by PrPC through Downregulating GSK3β Activity
Laia Lidón1,2,3,4, Laura Llaó-Hierro1,2,3,4, Mario Nuvolone5,6
1Molecular and Cellular Neurobiotechnology, Institute for Bioengineering of Catalonia (IBEC), Scientific Park of Barcelona, The Barcelona Institute for Science and Technology (BIST), 08028 Barcelona, Spain.
Abstract:
Tau protein is largely responsible for tauopathies, including Alzheimer's disease (AD), where it accumulates in the brain as insoluble aggregates. Tau mRNA is regulated by alternative splicing, and inclusion or exclusion of exon 10 gives rise to the 3R and 4R isoforms respectively, whose balance is physiologically regulated. In this sense, one of the several factors that regulate alternative splicing of tau is GSK3β, whose activity is inhibited by the cellular prion protein (PrPC), which has different physiological functions in neuroprotection and neuronal differentiation. Moreover, a relationship between PrPC and tau expression levels has been reported during AD evolution. For this reason, in this study we aimed to analyze the role of PrPC and the implication of GSK3β in the regulation of tau exon 10 alternative splicing. We used AD human samples and mouse models of PrPC ablation and tau overexpression. In addition, we used primary neuronal cultures to develop functional studies. Our results revealed a paralleled association between PrPC expression and tau 4R isoforms in all models analyzed. In this sense, reduction or ablation of PrPC levels induces an increase in tau 3R/4R balance. More relevantly, our data points to GSK3β activity downstream from PrPC in this phenomenon. Our results indicate that PrPC plays a role in tau exon 10 inclusion through the inhibitory capacity of GSK3β.
Insights
Cellular prion protein (PrPC) influences tau splicing, impacting Alzheimer's disease pathology. Reduced PrPC increases 4R tau isoforms by affecting GSK3β activity, suggesting a novel therapeutic target.
Area of Science:
- Neuroscience
- Molecular Biology
- Biochemistry
Background:
- Tau protein aggregation causes tauopathies, including Alzheimer's disease (AD).
- Tau mRNA alternative splicing, regulated by exon 10 inclusion/exclusion, determines 3R and 4R tau isoform balance.
- Cellular prion protein (PrPC) modulates GSK3β activity, a key regulator of tau splicing.
Purpose of the Study:
- To investigate the role of PrPC in regulating tau exon 10 alternative splicing.
- To elucidate the involvement of GSK3β in the PrPC-mediated tau splicing mechanism.
Main Methods:
- Analysis of Alzheimer's disease human samples.
- Utilized mouse models with PrPC ablation and tau overexpression.
- Functional studies using primary neuronal cultures.
Main Results:
- A parallel association was observed between PrPC expression and tau 4R isoforms across all models.
- Reduction or ablation of PrPC led to an increased tau 3R/4R isoform ratio.
- GSK3β activity was identified downstream of PrPC in regulating tau splicing.
Conclusions:
- PrPC plays a significant role in tau exon 10 inclusion.
- PrPC exerts its influence on tau splicing through the inhibition of GSK3β activity.
- This mechanism highlights a novel pathway linking PrPC to tauopathy pathogenesis.
More Related Videos
09:29Electroporation-Based CRISPR-Cas9-Mediated Gene Knockout in THP-1 Cells and Single-Cell Clone Isolation
Published on: February 28, 2025
09:34Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
Related Concept Videos
GPCR Desensitization
Exon Recombination
Exon shuffling follows “splice frame rules.” Each exon...
GPCRs Regulate Adenylyl Cylase Activity
TGF - β Signaling Pathway
Regulation of the Unfolded Protein Response